Lung deposition and clearance of inhaled 99mTc-heparin in healthy volunteers

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1653-1658

  Bendstrup, Karen E ^b   Chambers, Carole B ^b   Jensen, Jens I ^a   Newhouse, Michael T ^b  

^a ESBJERG HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TECHNETIUM 99M;

ARTICLE; BLOOD CLOTTING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MIXTURE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT; LUNG; LUNG SCINTISCANNING; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032696014     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9809123     Document Type: Article

References (27)

1. Garrigo, J., I. Danta, and T. Ahmed. 1996. Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am. J. Respir. Crit. Care Med. 153:1702-1707.
2. Diamant, Z., M. C. Timmers, H. van der Veen, C. Page, F. J. van der Meer, and P. J. Sterk. 1996. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 153:1790-1795.
3. Kuna, P., and M. Antezak. 1995. The effect of inhaled heparin on allergen induced bronchial hyperresponsiveness in asthmatic patients. Allergy 50(Suppl. 25):25-26.
4. Kalpaklioglu, A. F., Y. S. Demirel, S. Saryal, and Z. Misirgil. 1997. Effect of pretreatment with heparin on pulmonary and cutaneous response. J. Asthma 34:337-343.
5. Ceyhan, B., and T. Celikel. 1997. Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity. Int. J. Clin. Pharmacol. Ther. 35: 208-213.
6. Crimi, N., R. Polossa, S. Magri, F. Armato, G. Santonocito, and A. Mistretta. 1995. Attenuation of the airways responsiveness to AMP by inhaled heparin in asthmatic subjects (abstract). Am. J. Respir. Crit. Care Med. 151:A130.
7. Pavord, I., T. Mudassar, J. Bennets, P. Wilding, and A. Knox. 1996. The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Eur. Respir. J. 9:217-219.
8. Bendstrup, K. E., M. T. Newhouse, O. F. Pedersen, and J. I. Jensen. 1998. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers. J. Aerosol Med. 12:17-25.
9. 99mTc-heparin aerosols (abstract). Am. J. Respir. Crit. Care Med. 157:A821.
10. Phipps, P. R., I. Gonda, and S. A. Anderson. 1992. Apparatus for the control of breathing patterns during aerosol inhalation. J. Aerosol Med. 5:155-170,
11. Allen, T. H., M. T. Pery, K. P. Chen, T. F. Huang, C. Chang, and H. S. Fang. 1956. Prediction of blood volume and adiposity in man from body weight and cube of height. Metabolism 5:328.
12. Gouin-Thibault, I., L. Dewar, M. Kulczycky, M. Stembach, and F. A. Ofosu. 1995. Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivo. Br. J. Haematol. 90:669-680.
13. Gouin-Thibault, I., L. Dewar, S. Craven, M. Kulczycky, T. C. Wun, and F. A. Ofosu. 1996. Probable regulation of factor VIIa-tissue factor and prothromhinasc by factor Xa-TFPI and TFPI in vivo. Br. J. Haematol. 95:738-746.
14. Hafner, G., H. Schinzel, W. Ehrenthal, C. Wagner, U. Konheiser, R. Zotz, J. Lotz, R. Blank, L. S. Weilmann, and W. Prellwitz. 1993. Influence of blood sampling from venipuncture and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex. Ann. Hematol. 76:121-125.
15. Marshall, L. M., P. W. Francis, and F. A. Khafagi. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J. Paediatr. Child Health 30:65-67.
16. Devadason, S. G., M. L. Everard, J. M. Linto, and P. N. Le Souëf. 1997. Comparison of drug delivery from conventional versus "venturi" nebulizers. Eur. Respir. J. 10:2479-2483.
17. Esquerré, J. P., B. Boneu, and R. Guiraud. 1979. Kinetics of technetium-labeled heparin in thromboembolism: preliminary report. Int. J. Nucl. Med. Biol. 6:215-220.
18. 99mTechnetium is not an appropriate radiolabel for in vivo studies of heparin. Thromb. Haemost. 65:1295.
19. Yeates, D. B., N. Aspin, A. C. Bryan, and H. Levison. 1973. Regional clearance of ions from the airways of the lung. Am. Rev. Respir. Dis. 107:602-608.
20. Jaques, L. B., J. Mahadoo, and L. W. Kavanagh. 1976. Intrapulmonary heparin: a new procedure for anticoagulant therapy. Lancet 7996:1157-1161,
21. Mahadoo, J., and L. B. Jaques. 1979. Cellular control of heparin in blood. Med. Hypotheses 5:835-841.
22. Hellgren, M., K. Hägnevik, and M. Blombäck. 1981. Heparin aerosol - effect on blood coagulation and pulmonary function. Thromb. Res. 21: 493-502.
23. Mahadoo, J., L. M. Hiebert, and L. B. Jaques. 1977. Vascular sequestration of heparin. Thromb. Res. 12:79-90.
24. Mahadoo, J., L. M. Hiebert, C. J. Wright, and L. B. Jaques. 1982. Vascular distribution of intratracheally administered heparin. Ann. N.Y. Acad. Sci. 370:650-661.
25. Ahmed, T., J. Garrigo, and I. Danta. 1993. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329:90-91.
26. Kim, G. S., and T.C. Kang. 1997. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. Am. J. Respir. Crit. Care Med. 155:899-905.
27. 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 113:1573-1579.